Clinical Trial Update: Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating mecobalamin to prevent taxane-related peripheral neuropathy. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Mecobalamin (mecobalamin)

Snippet

Sponsor: Qinghai Red Cross Hospital | Conditions: Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathy, Chemotherapy-induced | Phase 3 | Status: RECRUITING